2nd Quarter - Report

TIBER CREEK GROUP for JAZZ PHARMACEUTICALS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3032 (117th)

Medical/Disease Research/Clinical Labs MED

Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3032 (117th)

Budget/Appropriations BUD

Appropriations issues related to the House Ag/ FDA Appropriations bill pertaining to FDA enforcement of non-FDA approved, cannabis derived CBD products.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.